AI in Medicine News ・ 💊 Drug discovery and clinical trials

3billion Signs AI Drug Discovery Collaboration Agreement with DeepLife

3billion · 11/10 07:13 UTC

3billion has signed a Master Co-Development Agreement with DeepLife. The deal combines genomic data from more than 120,000 individuals with AI virtual-cell technology for therapeutic target discovery, validation, and drug candidate development.

Read the original (3billion)

See it in the digest → ・ See this issue →